Israel - English - Ministry of Health

inovamed ltd - quetiapine as fumarate - tablets prolonged release - quetiapine as fumarate 50 mg - quetiapine - quetiapine inovamed sr is indicated for the treatment of schizophrenia. quetiapine inovamed sr is effective in preventing relapse in stable schizophrenic patients who have been maintained on quetiapine inovamed sr. quetiapine inovamed sr is indicated for the treatment of moderate to severe manic episodes associated with bipolar disorder. quetiapine inovamed sr is indicated for the treatment of major depressive episodes in bipolar disorder. treatment of acute mania associated with bipolar i disorder as monotherapy or in combination with lithium or sodium valproate. quetiapine inovamed sr is indicated for preventing recurrence in bipolar disorder in patients whose manic, mixed or depressive episode has responded to quetiapine treatment, as monotherapy or in combination with lithium or sodium valproate. quetiapine inovamed sr is indicated for add-on treatment of major depressive episods in patients with major depressive disorder (mdd) who have had sub-optimal response to antidepressant monotherapy. prior to initiating treatment, clinicians should consider the safety profile of quetiapine inovamed sr.

Israel - English - Ministry of Health

novartis israel ltd - quetiapine as fumarate - tablets prolonged release - quetiapine as fumarate 150 mg - quetiapine - quetiapine sandoz prt is indicated for the treatment of schizophrenia. quetiapine sandoz prt is effective in preventing relapse in stable schizophrenic patients who have been maintained on quetiapine sandoz prt. quetiapine sandoz prt is indicated for the treatment of moderate to severe manic episodes associated with bipolar disorder.treatment of acute mania associated with bipolar i disorder as monotherapy or in combination with lithium or sodium valproate. quetiapine sandoz prt is indicated for the treatment of major depressive episodes in bipolar disorder. quetiapine sandoz prt is indicated for preventing recurrence in bipolar disorder in patients whose manic, mixed or depressive episode has responded to quetiapine treatment as monotherapy or in combination with lithium or sodium valproate. quetiapine sandoz prt is indicated for add-on treatment of major depressive episods in patients with major depressive disorder (mdd) who have had sub-optimal response to antidepressant monotherapy . prior to initiating treatment, clinicians should consider the safety profile of quetiapine sandoz prt.

Israel - English - Ministry of Health

novartis israel ltd - quetiapine as fumarate - tablets prolonged release - quetiapine as fumarate 200 mg - quetiapine - quetiapine sandoz prt is indicated for the treatment of schizophrenia. quetiapine sandoz prt is effective in preventing relapse in stable schizophrenic patients who have been maintained on quetiapine sandoz prt. quetiapine sandoz prt is indicated for the treatment of moderate to severe manic episodes associated with bipolar disorder.treatment of acute mania associated with bipolar i disorder as monotherapy or in combination with lithium or sodium valproate. quetiapine sandoz prt is indicated for the treatment of major depressive episodes in bipolar disorder. quetiapine sandoz prt is indicated for preventing recurrence in bipolar disorder in patients whose manic, mixed or depressive episode has responded to quetiapine treatment as monotherapy or in combination with lithium or sodium valproate. quetiapine sandoz prt is indicated for add-on treatment of major depressive episods in patients with major depressive disorder (mdd) who have had sub-optimal response to antidepressant monotherapy . prior to initiating treatment, clinicians should consider the safety profile of quetiapine sandoz prt.

Israel - English - Ministry of Health

novartis israel ltd - quetiapine as fumarate - tablets prolonged release - quetiapine as fumarate 300 mg - quetiapine - quetiapine sandoz prt is indicated for the treatment of schizophrenia. quetiapine sandoz prt is effective in preventing relapse in stable schizophrenic patients who have been maintained on quetiapine sandoz prt. quetiapine sandoz prt is indicated for the treatment of moderate to severe manic episodes associated with bipolar disorder.treatment of acute mania associated with bipolar i disorder as monotherapy or in combination with lithium or sodium valproate. quetiapine sandoz prt is indicated for the treatment of major depressive episodes in bipolar disorder. quetiapine sandoz prt is indicated for preventing recurrence in bipolar disorder in patients whose manic, mixed or depressive episode has responded to quetiapine treatment as monotherapy or in combination with lithium or sodium valproate. quetiapine sandoz prt is indicated for add-on treatment of major depressive episods in patients with major depressive disorder (mdd) who have had sub-optimal response to antidepressant monotherapy . prior to initiating treatment, clinicians should consider the safety profile of quetiapine sandoz prt.

Israel - English - Ministry of Health

novartis israel ltd - quetiapine as fumarate - tablets prolonged release - quetiapine as fumarate 400 mg - quetiapine - quetiapine sandoz prt is indicated for the treatment of schizophrenia. quetiapine sandoz prt is effective in preventing relapse in stable schizophrenic patients who have been maintained on quetiapine sandoz prt. quetiapine sandoz prt is indicated for the treatment of moderate to severe manic episodes associated with bipolar disorder.treatment of acute mania associated with bipolar i disorder as monotherapy or in combination with lithium or sodium valproate. quetiapine sandoz prt is indicated for the treatment of major depressive episodes in bipolar disorder. quetiapine sandoz prt is indicated for preventing recurrence in bipolar disorder in patients whose manic, mixed or depressive episode has responded to quetiapine treatment as monotherapy or in combination with lithium or sodium valproate. quetiapine sandoz prt is indicated for add-on treatment of major depressive episods in patients with major depressive disorder (mdd) who have had sub-optimal response to antidepressant monotherapy . prior to initiating treatment, clinicians should consider the safety profile of quetiapine sandoz prt.

Israel - English - Ministry of Health

novartis israel ltd - quetiapine as fumarate - tablets prolonged release - quetiapine as fumarate 50 mg - quetiapine - quetiapine sandoz prt is indicated for the treatment of schizophrenia. quetiapine sandoz prt is effective in preventing relapse in stable schizophrenic patients who have been maintained on quetiapine sandoz prt. quetiapine sandoz prt is indicated for the treatment of moderate to severe manic episodes associated with bipolar disorder.treatment of acute mania associated with bipolar i disorder as monotherapy or in combination with lithium or sodium valproate. quetiapine sandoz prt is indicated for the treatment of major depressive episodes in bipolar disorder. quetiapine sandoz prt is indicated for preventing recurrence in bipolar disorder in patients whose manic, mixed or depressive episode has responded to quetiapine treatment as monotherapy or in combination with lithium or sodium valproate. quetiapine sandoz prt is indicated for add-on treatment of major depressive episods in patients with major depressive disorder (mdd) who have had sub-optimal response to antidepressant monotherapy . prior to initiating treatment, clinicians should consider the safety profile of quetiapine sandoz prt.

United States - English - NLM (National Library of Medicine)

citron pharma llc - quetiapine fumarate (unii: 2s3pl1b6uj) (quetiapine - unii:bgl0jsy5si) - quetiapine 25 mg - quetiapine fumarate tablets are indicated for the treatment of schizophrenia. the efficacy of quetiapine fumarate tablets in schizophrenia was established in three 6-week trials in adults and one 6-week trial in adolescents (13 to 17 years). the effectiveness of quetiapine fumarate tablets for the maintenance treatment of schizophrenia has not been systematically evaluated in controlled clinical trials [see clinical studies (14.1)] . quetiapine fumarate tablets are indicated for the acute treatment of manic episodes associated with bipolar i disorder, both as monotherapy and as an adjunct to lithium or divalproex. efficacy was established in two 12-week monotherapy trials in adults, in one 3-week adjunctive trial in adults, and in one 3-week monotherapy trial in pediatric patients (10 to 17 years) [see clinical studies (14.2)] . quetiapine fumarate tablets are indicated as monotherapy for the acute treatment of depressive episodes associated with bipolar disorder. efficacy was established in two 8-week mo

United States - English - NLM (National Library of Medicine)

sciegen pharmaceuticals, inc - quetiapine fumarate (unii: 2s3pl1b6uj) (quetiapine - unii:bgl0jsy5si) - quetiapine 150 mg - quetiapine extended-release tablets are indicated for the treatment of schizophrenia. the efficacy of quetiapine extended-release tablets in schizophrenia was established in one 6-week and one maintenance trial in adults with schizophrenia. efficacy was supported by three 6-week trials in adults with schizophrenia and one 6-week trial in adolescents with schizophrenia (13 to 17 years) treated with quetiapine tablets [see clinical studies (14.1)]. quetiapine extended-release tablets are indicated for the acute treatment of manic or mixed episodes associated with bipolar i disorder, both as monotherapy and as an adjunct to lithium or divalproex. the efficacy of quetiapine extended-release tablets in manic or mixed episodes of bipolar i disorder was established in one 3-week trial in adults with manic or mixed episodes associated with bipolar i disorder. efficacy was supported by two 12-week monotherapy trials and one 3-week adjunctive trial in ad

United States - English - NLM (National Library of Medicine)

marlex pharmaceuticals inc - quetiapine fumarate (unii: 2s3pl1b6uj) (quetiapine - unii:bgl0jsy5si) - quetiapine 150 mg - quetiapine extended-release tablets are indicated for the treatment of schizophrenia. the efficacy of quetiapine extended-release tablets in schizophrenia was established in one 6-week and one maintenance trial in adults with schizophrenia. efficacy was supported by three 6-week trials in adults with schizophrenia and one 6-week trial in adolescents with schizophrenia (13 to 17 years) treated with quetiapine tablets [see clinical studies ( 14.1 )]. quetiapine extended-release tablets are indicated for the acute treatment of manic or mixed episodes associated with bipolar i disorder, both as monotherapy and as an adjunct to lithium or divalproex. the efficacy of quetiapine extended-release tablets in manic or mixed episodes of bipolar i disorder was established in one 3-week trial in adults with manic or mixed episodes associated with bipolar i disorder. efficacy was supported by two 12-week monotherapy trials and one 3-week adjunctive trial in adults with manic episodes associated with bipolar i disorder as

United States - English - NLM (National Library of Medicine)

aci healthcare usa, inc. - quetiapine fumarate (unii: 2s3pl1b6uj) (quetiapine - unii:bgl0jsy5si) - quetiapine 150 mg - quetiapine extended-release tablets are indicated for the treatment of schizophrenia. the efficacy of quetiapine extended-release tablets in schizophrenia was established in one 6-week and one maintenance trial in adults with schizophrenia. efficacy was supported by three 6-week trials in adults with schizophrenia and one 6-week trial in adolescents with schizophrenia (13 to 17 years) treated with quetiapine tablets [see clinical studies (14.1)]. quetiapine extended-release tablets are indicated for the acute treatment of manic or mixed episodes associated with bipolar i disorder, both as monotherapy and as an adjunct to lithium or divalproex. the efficacy of quetiapine extended-release tablets in manic or mixed episodes of bipolar i disorder was established in one 3-week trial in adults with manic or mixed episodes associated with bipolar i disorder. efficacy was supported by two 12-week monotherapy trials and one 3-week adjunctive trial in adults with manic episodes associated with bipolar i disorder as wel